NIH unveils unified strategy to strengthen research priorities, real-world data, and public trust

The US National Institutes of Health (NIH) has announced a unified strategy designed to sharpen research priorities, accelerate evidence generation, and expand the use of real-world data (RWD) as part of efforts to rebuild public trust. Amid ongoing questions about how the agency sets priorities and manages taxpayer resources, the strategy is intended to bring greater clarity and coherence to the NIH’s mission.

A central feature is the development of a national Real-World Data Platform, first outlined by NIH Director Dr Jay Bhattacharya in April 2025. The platform will securely integrate claims data, electronic health records, and other real-world sources, providing advanced analytic capacity to investigate chronic disease, neurodevelopmental disorders, and other major health burdens. According to the NIH, this infrastructure is intended to generate more representative, scalable evidence that complements traditional clinical trials.

The strategy also prioritizes replication and reproducibility, with plans to expand funding for replication studies and encourage the publication of negative results. By countering the “publish or perish” culture, the NIH aims to strengthen confidence in biomedical research outcomes. AI is another focus, with the agency developing a strategic plan to improve transparency in model development, establish replication standards, and validate applications in healthcare. Other priorities include expanded nutrition research, greater use of non-animal testing models, and new initiatives in autism etiology.

In addition, the NIH will support research grounded in measurable factors that directly influence health outcomes, such as demographics, environmental exposures, and socioeconomic conditions, and move health disparities research beyond documenting gaps to testing interventions that can deliver measurable improvements in population health. As the report notes:

“Going forward, the NIH will prioritize research that goes beyond measuring health disparities to focusing on solution-oriented approaches. This includes actively testing, advancing, scaling, and implementing innovative evidence-based interventions and treatments that address poor health outcomes.”

The strategy coincides with a draft Make Our Children Healthy Again Strategy, dated August 11, which was obtained and reported by Politico. Issued by the Make America Healthy Again (MAHA) Commission, the draft outlines a government-wide approach to tackling childhood chronic disease by advancing research, realigning incentives, increasing public awareness, and fostering private sector collaboration. It identifies the NIH’s Real-World Data Platform as a cornerstone of this effort, alongside expanded commitments to replication studies and reproducibility.

The leaked MAHA strategy also offers further detail on how the NIH’s role fits within the wider federal agenda. It proposes the creation of a Task Force on Chronic Disease across the lifespan, convened by the NIH to align existing initiatives and improve interagency coordination. The task force would launch a Whole-Person-Health approach to prevention research, drawing on collective expertise to develop discovery science and interventions that promote resilience and long-term health. The draft also links the Real-World Data Platform directly to autism research, recommending collaboration between HHS, NIH, and CMS to study the root causes of autism, with the platform providing the analytic backbone.

Longitudinal data also feature prominently. The NIH is expected to leverage its extensive cohort portfolio, including the Adolescent Brain Cognitive Development Study, Healthy Brain and Child Development Study, All of Us Research Program, and Environmental Influences on Child Health Outcomes Program, to investigate root causes, modifiable risk factors, and prevention strategies. The Department of Veterans Affairs will complement this work by sharing data on more than 200,000 Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA) beneficiaries under 18, covering ADHD, diabetes, and pharmaceutical use. This collaboration is designed to fill longstanding gaps in pediatric research and inform national strategies for early intervention and mental health policy.

For the NIH, the overarching aim is to balance scientific opportunity with mission-critical needs while demonstrating careful stewardship of taxpayer funds. “Taxpayer dollars are a finite resource, entrusted to NIH officials to invest in the nation’s future,” the agency stated. “By transparently establishing priorities and aligning our goals, we aim to demonstrate to the American public that we take this commitment seriously—and that we are doing all we can to honor their trust.”